2019 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Desensitization

Date: Sunday, June 2, 2019

Time: 2:30pm-4:00pm

Location: Ballroom A

Session Type: Concurrent Session

Meeting: 2019 American Transplant Congress

2:30pm-2:42pm: Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

2:42pm-2:54pm: Evaluation of the Safety and Tolerability of Clazakizumab® (Anti-IL-6 Monoclonal) as a Desensitization Agent in Highly-HLA Sensitized ESRD Patients (nct03380962)

A. A. Vo, N. Ammerman, E. Huang, A. Peng, R. Najjar, S. Sethi, S. Williamsons, C. Myers, K. Lim, J. Choi, S. C. Jordan

2:54pm-3:06pm: Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies

C. Schinstock, A. Bentall, S. Byron, L. Cornell, M. Everly, M. Gandhi, M. Stegall

3:06pm-3:18pm: Safety and Efficacy of Imlifidase in Highly-Sensitized Kidney Transplant Patients: Results from a Phase 2 Study

S. C. Jordan¹, C. Legendre², N. Desai³, T. Lorant⁴, M. Bengtsson⁴, L. Laxmyr⁵, B. Lonze⁶, A. Vo¹, K. J. Wood⁷, C. Kjellman⁵, R. A. Montgomery⁶

3:18pm-3:30pm: Anti-HLA IgM Antibodies Are Reduced in Highly-HLA Sensitized Patients Transplanted after Imlifidase (IdeS) Treatment

X. Zhang¹, S. Jordan²

3:30pm-3:42pm: Eight-Year Outcomes Following ABO-Incompatible Kidney Transplantation Performed after Desensitization by Antigen-Unspecific Immunoadsorption Devices

C. Speer¹, F. Kälble¹, L. Pego da Silva¹, C. Nusshag¹, M. Schaier¹, C. Süsal², C. Sommerer¹, M. Zeier¹, C. Morath¹

3:42pm-3:54pm: Bortezomib Based Induction Therapy Decreases Delayed Graft Function in High Risk Kidney Transplantation

K. Mahendran¹, N. Koizumi², J. K. Melancon¹

« View all sessions from the 2019 American Transplant Congress